ClinicalTrials.Veeva

Menu

Predicting EONS in PPROM Patients (PEONS)

J

Jena University Hospital

Status

Enrolling

Conditions

PPROM
Early-Onset Neonatal Sepsis

Treatments

Diagnostic Test: Conventional cultures
Diagnostic Test: CAAP48 measurement
Diagnostic Test: microbiome analysis

Study type

Observational

Funder types

Other

Identifiers

NCT03819192
KG-PEONS

Details and patient eligibility

About

An EONS occurred in nearly 14-22 % of the preterm infant of pregnant women with PPROM. To this day no risk prediction is established. The main aim of this pilot study is generating primary data with a focus on the vaginal microbiome to set-up a prospective, multi-centre trial investigating the role of the vaginal microbiome for future EONS risk prediction.

The planned PEONS pilot trial is subdivided in three Work packages:

  1. Recruitment, sample collection and routine clinical diagnostics
  2. Microbiome analysis by 16S rRNA
  3. Microbiome/ Metagenome analysis by "Nanopore" (proof-of-principle) and will enroll women with a PPROM event hospitalized between 22+0 and 34+0 weeks of gestation and neonates with signs of EONS (Subgroup 1) and without signs of EONS (Subgroup 2).

Enrollment

150 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • full age pregnant woman with PPROM and their born preterm infants
  • hospitalization between 22+0 and 34+0 weeks of gestation
  • multipara possible

Exclusion criteria

  • hospitalization with PPROM before limit of viability are reached
  • intrauterine fetal death
  • no study agreement
  • not able to consent

Trial design

150 participants in 3 patient groups

neonates with signs of EONS
Treatment:
Diagnostic Test: microbiome analysis
Diagnostic Test: CAAP48 measurement
Diagnostic Test: Conventional cultures
neonates without signs of EONS
Treatment:
Diagnostic Test: microbiome analysis
Diagnostic Test: CAAP48 measurement
Diagnostic Test: Conventional cultures
pregnant women with PPROM
Treatment:
Diagnostic Test: microbiome analysis
Diagnostic Test: CAAP48 measurement
Diagnostic Test: Conventional cultures

Trial contacts and locations

2

Loading...

Central trial contact

Ekkehard Schleußner, Prof. Dr.; Janine Zöllkau, Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems